96.62

2.95% -2.385

Genedx Holdings Corp (WGS)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Genedx Holdings Corp stock is traded at $96.62, with a volume of 292.45K. It is down -2.95% in the last 24 hours and down -27.37% over the past month. GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

Previous Close:

$99.01

Open:

$98.74

24h Volume:

292.45K

Relative Volume:

0.53

Market Cap:

$2.78B

Revenue:

$267.23M

Net Income/Loss:

$-83.50M

P/E Ratio:

-31.07

EPS:

-3.11

Net Cash Flow:

$-59.99M

1W Performance:

+0.08%

1M Performance:

-27.37%

6M Performance:

-5.43%

1Y Performance:

+37.30%

1-Day Range:

$96.19

$101.94

1-Week Range:

$91.65

$101.94

52-Week Range:

$55.17

$170.87

Genedx Holdings Corp Stock (WGS) Company Profile

Name

Genedx Holdings Corp

Sector

Healthcare (1116)

Industry

Diagnostics & Research (53)

Phone

888-729-1206

Address

333 LUDLOW STREET, STAMFORD

Employee

1,000

Twitter

Next Earnings Date

2025-02-18

Latest SEC Filings

WGS's Discussions on Twitter

Compare WGS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
WGS Genedx Holdings Corp	96.34	2.86B	267.23M	-83.50M	-59.99M	-3.11
TMO Thermo Fisher Scientific Inc	570.09	218.58B	44.56B	6.73B	6.29B	17.74
DHR Danaher Corp	217.12	157.94B	24.57B	3.60B	5.25B	5.0475
IDXX Idexx Laboratories Inc	635.19	51.07B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	132.38	38.38B	6.95B	1.30B	1.15B	4.5696
IQV Iqvia Holdings Inc	209.15	39.38B	15.90B	1.28B	2.21B	7.2842

Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-20-25	Initiated	Canaccord Genuity	Buy
Jul-09-25	Initiated	Piper Sandler	Overweight
May-15-25	Initiated	Guggenheim	Buy
May-09-25	Upgrade	Jefferies	Hold → Buy
Aug-28-24	Initiated	Wells Fargo	Equal Weight
Jul-10-24	Initiated	Craig Hallum	Buy
Jun-03-24	Resumed	Jefferies	Hold

View All

Genedx Holdings Corp Stock (WGS) Latest News

08:07 AM

GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026 - marketscreener.com

08:07 AM

02:29 AM

GeneDx Holdings Corp. (NASDAQ:WGS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

02:29 AM

Feb 02, 2026

Insider Selling: GeneDx (NASDAQ:WGS) CFO Sells 317 Shares of Stock - MarketBeat

Feb 02, 2026

Jan 31, 2026

Fed Watch: Is GeneDx Holdings Corp Equity Warrant gaining market shareJuly 2025 Weekly Recap & Long-Term Safe Investment Ideas - baoquankhu1.vn

Jan 31, 2026

Jan 30, 2026

Trading Action: Should value investors consider Equifax IncWeekly Market Report & Consistent Income Trade Ideas - baoquankhu1.vn

Jan 30, 2026

Jan 29, 2026

Aug Gainers: Can GeneDx Holdings Corp expand its profit marginsMarket Performance Report & Stepwise Trade Execution Plans - baoquankhu1.vn

Jan 29, 2026

What makes GeneDx Holdings Corp. stock attractive todayJuly 2025 Technicals & Free Weekly Chart Analysis and Trade Guides - mfd.ru

Jan 29, 2026

Surging AI-Driven Genetic Testing Demand Might Change The Case For Investing In GeneDx Holdings (WGS) - Sahm

Jan 29, 2026

Jan 28, 2026

Can GeneDx Holdings Corp. stock double in the next yearInsider Buying & Safe Swing Trade Setups - mfd.ru

Jan 28, 2026

Universal Beteiligungs und Servicegesellschaft mbH Buys 17,936 Shares of GeneDx Holdings Corp. $WGS - MarketBeat

Jan 28, 2026

Why We're Not Concerned Yet About GeneDx Holdings Corp.'s (NASDAQ:WGS) 26% Share Price Plunge - 富途牛牛

Jan 28, 2026

Jan 27, 2026

GeneDx (NASDAQ:WGS) Stock Price Down 8.2%What's Next? - MarketBeat

Jan 27, 2026